The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
Armin Hatzelmann, Esteban J. Morcillo, Giuseppe Lungarella, Serge Adnot, Shahin Sanjar, Rolf Beume, Christian Schudt, Hermann TenorVolume:
23
Year:
2010
Language:
english
DOI:
10.1016/j.pupt.2010.03.011
File:
PDF, 663 KB
english, 2010